Composition
- Active ingredients
- BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE; NALOXONE HYDROCHLORIDE EQ 2MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE; NALOXONE HYDROCHLORIDE EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020733-001 · Discontinued
- BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE; NALOXONE HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020733-002 · Discontinued
- BUPRENORPHINE HYDROCHLORIDE EQ 12MG BASE; NALOXONE HYDROCHLORIDE EQ 3MG BASE · FilmNDA022410-004 · Prescription
- BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE; NALOXONE HYDROCHLORIDE EQ 2MG BASE · FilmThis page
- BUPRENORPHINE HYDROCHLORIDE EQ 4MG BASE; NALOXONE HYDROCHLORIDE EQ 1MG BASE · FilmNDA022410-003 · Prescription
- BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE; NALOXONE HYDROCHLORIDE EQ 0.5MG BASE · FilmNDA022410-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022410.